Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia

Population aging has challenged the treatment of cognitive impairment or dementia. Vascular dementia is the second leading cause of dementia after Alzheimer’s disease. Cognitive consequences after ischemic brain injury have been recognized as a preferred target for therapeutic strategies, prompting...

Descripción completa

Detalles Bibliográficos
Autores principales: Linh, Tran Thanh Duy, Hsieh, Yi-Chen, Huang, Li-Kai, Hu, Chaur-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569827/
https://www.ncbi.nlm.nih.gov/pubmed/36232368
http://dx.doi.org/10.3390/ijms231911067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569827/
https://www.ncbi.nlm.nih.gov/pubmed/36232368
http://dx.doi.org/10.3390/ijms231911067

Ejemplares similares